Genor Biopharma Holdings Ltd

FRA:67N0 (China)   Ordinary Shares
€ 0.17 (-3.39%) Dec 10
At Loss
P/B:
0.72
Market Cap:
€ 97.56M ($ 102.37M)
Enterprise V:
€ -35.97M ($ -37.75M)
Volume:
-
Avg Vol (2M):
40.00K
Trade In:

Business Description

Description
Genor Biopharma Holdings Ltd is a commercial-ready biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. The company is focused on therapeutic areas with substantial unmet medical needs in oncology, autoimmune, and other chronic diseases. Its key drug candidates include GB491 (lerociclib), a differentiated oral CDK4/6 inhibitor; GB221, a novel HER2 mAb drug candidate; geptanolimab (GB226), GB492, a STING agonist expected to exert synergistic effects in combination with GB226; GB242, an infliximab (Remicade) biosimilar; and GB223, a RANKL, and others.
Name Current Vs Industry Vs History
Cash-To-Debt 326.1
Equity-to-Asset 0.83
Debt-to-EBITDA -0.01
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 66.39
9-Day RSI 56.61
14-Day RSI 50.45
6-1 Month Momentum % 51.91
12-1 Month Momentum % 61.79

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.76
Quick Ratio 5.73
Cash Ratio 5.41
Days Inventory 15829.29
Days Payable 136686.68

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.9
Shareholder Yield % 3.45

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 97.59
Operating Margin % -3679.81
Net Margin % -3675.83
FCF Margin % -2363.68
ROE % -41.35
ROA % -34.63
ROIC % -185.02
ROC (Joel Greenblatt) % -526.02
ROCE % -39.84

Financials

FRA:67N0's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Genor Biopharma Holdings Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 1.853
EPS (TTM) (€) -0.133
Beta 0.54
Volatility % 78.18
14-Day RSI 50.45
14-Day ATR (€) 0.004566
20-Day SMA (€) 0.1644
12-1 Month Momentum % 61.79
52-Week Range (€) 0.0845 - 0.256
Shares Outstanding (Mil) 516.51

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Genor Biopharma Holdings Ltd Filings

Filing Date Document Date Form
No Filing Data

Genor Biopharma Holdings Ltd Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Genor Biopharma Holdings Ltd Frequently Asked Questions

What is Genor Biopharma Holdings Ltd(FRA:67N0)'s stock price today?
The current price of FRA:67N0 is €0.17. The 52 week high of FRA:67N0 is €0.26 and 52 week low is €0.08.
When is next earnings date of Genor Biopharma Holdings Ltd(FRA:67N0)?
The next earnings date of Genor Biopharma Holdings Ltd(FRA:67N0) is .
Does Genor Biopharma Holdings Ltd(FRA:67N0) pay dividends? If so, how much?
Genor Biopharma Holdings Ltd(FRA:67N0) does not pay dividend.

Press Release

Subject Date
No Press Release